Literature DB >> 9090336

MRI-defined vascular depression.

K R Krishnan1, J C Hays, D G Blazer.   

Abstract

OBJECTIVE: The authors' goal was to characterize the clinical and demographic features of vascular depression.
METHOD: They classified 89 depressed patients into two groups-those with vascular (N = 32) and nonvascular (N = 57) depression-on the basis of examination of brain magnetic resonance images. All of the patients were enrolled in the National Institute of Mental Health Clinical Research Center for the Study of Depression in Later Life, located at Duke University. The patients with vascular and nonvascular depression were compared on several clinical and demographic risk factors.
RESULTS: Bivariate analyses and a fully adjusted logistic regression model revealed that older age, late age at onset, and nonpsychotic subtype occurred more often in patients with vascular depression than in those with nonvascular depression. A family history of mental illness was found somewhat less often, and anhedonia and functional disability were seen somewhat more often in patients with vascular depression.
CONCLUSIONS: The profile of patients with vascular depression needs to be developed further. This is likely to have important therapeutic and theoretical implications for the management of these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9090336     DOI: 10.1176/ajp.154.4.497

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  170 in total

1.  A neuropathological study of vascular factors in late-life depression.

Authors:  A J Thomas; I N Ferrier; R N Kalaria; R H Perry; A Brown; J T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

Review 2.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 3.  The emotion paradox in the aging brain.

Authors:  Mara Mather
Journal:  Ann N Y Acad Sci       Date:  2012-03-12       Impact factor: 5.691

Review 4.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

Review 5.  Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review.

Authors:  John L Beyer; Robert Young; Maragatha Kuchibhatla; K Ranga R Krishnan
Journal:  Int Rev Psychiatry       Date:  2009

6.  Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.

Authors:  Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-02-28       Impact factor: 2.680

7.  Mapping callosal morphology in early- and late-onset elderly depression: an index of distinct changes in cortical connectivity.

Authors:  Martina Ballmaier; Anand Kumar; Virginia Elderkin-Thompson; Katherine L Narr; Eileen Luders; Paul M Thompson; Cornelius Hojatkashani; Daniel Pham; Andreas Heinz; Arthur W Toga
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

Review 8.  Ischaemic stroke in young adults: risk factors and long-term consequences.

Authors:  Noortje A M M Maaijwee; Loes C A Rutten-Jacobs; Pauline Schaapsmeerders; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Nat Rev Neurol       Date:  2014-04-29       Impact factor: 42.937

Review 9.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

10.  Vascular lesions and functional limitations among older adults: does depression make a difference?

Authors:  Celia F Hybels; Carl F Pieper; Lawrence R Landerman; Martha E Payne; David C Steffens
Journal:  Int Psychogeriatr       Date:  2014-05-09       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.